Cell and Gene COGs: Words Of Wisdom To ‘Keep The End In Mind'
Source: Cell & Gene Collaborative
By Anna Rose Welch, Director, Cell & Gene Collaborative
When considering whether to invest limited funds in making critical manufacturing improvements early in development, the phrase “It’s either going to cost a lot now, or a lot more later” is no doubt one with which many cell and gene therapy CMC experts are familiar. In fact, this was one of the many snippets of wisdom shared during a recent Cell & Gene Collaborative discussion group featuring Dark Horse Consulting’s COO, Katy Spink.
As we approached the beginning of 2023, I invited Spink to join me and Cell & Gene Collaborative members for what turned into a lively discussion.
Read the rest of this article here:
